肺がんにおける腸内微生物群:病原性から精密療法まで
Miao Shi1, Long-Fei Wang1, Wen-Tao Hu1
1Department of Thoracic Surgery, First Affiliated Hospital of Ningbo University, Ningbo, China.
Frontiers in microbiology
|September 5, 2025
まとめ
腸内細菌を変えることで 肺がんの治療が改善されるかもしれません このレビューでは 腸内微生物群が肺がんにどのように影響し プロバイオティクスのような標的型治療法について議論しています
科学分野:
- 腫瘍学
- 免疫学
- 微生物群の研究
背景:
- 腸内微生物群は 免疫反応とがん治療の有効性に大きな影響を与えます
- 腸障害 (微生物の不均衡) は,進行がんにおける免疫チェックポイント阻害剤 (ICI) に対する耐性に関連しています.
- 腸-肺軸は 腸の微生物と肺の健康とのつながりで 肺がんを理解する上で 極めて重要です
研究 の 目的:
- 肺がんにおける腸内微生物の役割に関する 現在の理解を振り返るため
- 肺がんの発生と治療への反応に関連した微生物のシグネチャーを調べる
- 肺がん管理のための潜在的微生物群を標的とした介入について議論する.
主な方法:
- 腸内微生物と肺がんに関する最新の研究をまとめました
- 病気と治療への反応を予測する微生物のサインの分析
- 微生物と免疫の相互作用に関するメカニズム的洞察の探求
主要な成果:
- 腸内微生物群は肺がんの発生と進行に 重要な役割を果たします
- 特定の微生物のプロファイルは,ICIを含む治療に対する患者の反応を予測することができます.
- 微生物群を標的とした介入は 肺がん治療の改善に 期待を寄せています
結論:
- 腸内微生物群は肺がんの病原化と 治療効果の決定的な要因です
- 腸内微生物群をターゲットにすることで 肺がんの個別化管理に 有望な戦略が生まれます
- 腸肺軸と微生物介入に関するさらなる研究が必要である.
関連する概念動画
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Microorganisms in Medicine and Therapeutics
311
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
311
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K

